Related references
Note: Only part of the references are listed.Biomarker-guided therapy for colorectal cancer: strength in complexity
Anita Sveen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Gerhard Jung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells
Ya-Hui Huang et al.
CELLS (2020)
A Retrospective Exploration of Targeted Maintenance Therapy in Advanced Colorectal Cancer: Based on the Background of Chinese Patient Assistance Program
Hanguang Hu et al.
FRONTIERS IN ONCOLOGY (2020)
Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
Jingsi Dong et al.
FRONTIERS IN PHARMACOLOGY (2019)
Early colorectal cancer: diagnosis, treatment and survivorship care
Gabriella Buccafusca et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Targeting CDK1 and MEK/ERK Overcomes Apoptotic Resistance in BRAF-Mutant Human Colorectal Cancer
Peng Zhang et al.
MOLECULAR CANCER RESEARCH (2018)
The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
Promising New Agents for Colorectal Cancer
Satya Das et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
Chuan Xing Wu et al.
THERANOSTICS (2018)
From tumour heterogeneity to advances in precision treatment of colorectal cancer
Cornelis J. A. Punt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer
Guanli Huang et al.
ONCOLOGY REPORTS (2017)
Colorectal cancer heterogeneity and targeted therapy: Clinical implications, challenges and solutions for treatment resistance
Zhenhua Zhai et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Human dipeptidyl peptidase III regulates G-protein coupled receptor-dependent Ca2+ concentration in human embryonic kidney 293T cells
Subhash C. Prajapati et al.
BIOLOGICAL CHEMISTRY (2016)
Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
Wookyeom Yang et al.
ONCOTARGET (2016)
Apoptotic pathways as a therapeutic target for colorectal cancer treatment
Aman M. Abraha et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Molecular Mechanisms of Apoptosis and Roles in Cancer Development and Treatment
Samira Goldar et al.
Asian Pacific Journal of Cancer Prevention (2015)
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review
Benoist Chibaudel et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination
Bridgid E. Hast et al.
CANCER RESEARCH (2013)
Dipeptidyl peptidase III: a multifaceted oligopeptide N-end cutter
Subhash C. Prajapati et al.
FEBS JOURNAL (2011)
Ets-1/Elk-1 is a critical mediator of dipeptidyl-peptidase III transcription in human glioblastoma cells
Abhay A. Shukla et al.
FEBS JOURNAL (2010)
CXCL12 Chemokine Expression and Secretion Regulates Colorectal Carcinoma Cell Anoikis through Bim-Mediated Intrinsic Apoptosis
Luke J. Drury et al.
PLOS ONE (2010)
An overview of Cdk1-controlled targets and processes
Jorrit M. Enserink et al.
CELL DIVISION (2010)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
Caspases in apoptosis and beyond
J. Li et al.
ONCOGENE (2008)
Cdk1 is sufficient to drive the mammalian cell cycle
David Santamaria et al.
NATURE (2007)
p53 in health and disease
Karen H. Vousden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
What are caspases 3 and 7 doing upstream of the mitochondria?
Kageaki Kuribayashi et al.
CANCER BIOLOGY & THERAPY (2006)
Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas
S Simaga et al.
GYNECOLOGIC ONCOLOGY (2003)
Identification of Omi/HtrA-2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction
R Hegde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Assignment of the dipeptidyl peptidase III gene (DPP3) to human chromosome 11 band q12 -> q13.1 by in situ hybridization
KM Fukasawa et al.
CYTOGENETICS AND CELL GENETICS (2000)